Perhaps I missed something, but why wouldn't the FDA request both VRTX and IDIX use the same metrics - assay cutoffs in their studies. If I read correctly, VRTX results are based on a cutoff of 10 IU, while IDIX results are at a cutoff of 20 IU. This to me seems very significant.